Navigation Links
ev3 Inc. to Present at the FBR Capital Markets 12th Annual Spring Investor Conference
Date:5/15/2008

PLYMOUTH, Minn., May 15 /PRNewswire-FirstCall/ -- ev3 Inc. (Nasdaq: EVVV) today announced that Pat Spangler, senior vice president and chief financial officer, is scheduled to present at the 2008 FBR Capital Markets Spring Investor Conference on Thursday, May 29, 2008 at 2:20 p.m. Eastern Time (1:20 p.m. Central Time and 11:20 a.m. Pacific Time). The 2008 FBR Capital Markets Spring Investor Conference will be held at the Grand Hyatt Hotel, located at 109 East 42nd Street, New York, NY.

To access the webcast, go to the investors' section of the ev3 Web site at http://www.ev3.net and click on the Webcast icon. The Webcast will be available for replay approximately one hour after the presentation is complete.

About ev3 Inc.

Since its founding in 2000, ev3 has been dedicated to improving the lives of patients with vascular disease through the development of innovative endovascular therapies. ev3's products are used by endovascular specialists to treat a wide range of peripheral vascular and neurovascular diseases and disorders. The company offers a comprehensive portfolio of treatment options, including the primary interventional technologies used today -- peripheral angioplasty balloons, stents, plaque excision systems, embolic protection devices, liquid embolics, embolization coils, thrombectomy catheters and occlusion balloons. More information about the company and its products can be found at http://www.ev3.net.

ev3 and the ev3 logo are trademarks of ev3 Inc., registered in the U.S. and other countries.


'/>"/>
SOURCE ev3 Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. The California Dental Association Foundation Presents Inaugural Humanitarian Award to USC Mobile Dental Clinics Champion Charles M. Goldstein, DDS, MPH
2. HealthSouth to Present at the 2008 Citigroup Global Healthcare Conference and Jefferies 2nd Annual Healthcare Conference
3. HeartWare to Present at Seventh Annual JMP Securities Research Conference
4. Mindray to Present at the Oppenheimer 2nd Annual China Dragon Call Conference and 2008 Citi Investment Research Global Healthcare Conference
5. Pharmasset to Present at the Rodman & Renshaw Healthcare Conference on Tuesday, May 20th
6. Sunesis Pharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
7. China Sky One Medical, Inc. to Present at Brean Murray Carret & Co. All-Cap All-China Conference
8. EntreMed to Present at The Rodman and Renshaw 5th Annual Global Healthcare Conference
9. Emphasys Medical to Present VENT Clinical Trial Data at ATS 2008
10. PAREXEL International to Present at Robert W. Bairds 2008 Growth Stock Conference
11. Tianyin Pharmaceutical to Present at Roth Third Annual China Discovery Tour in Beijing on May 20, 2008 at 12:40 p.m. Beijing Time
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2017)... ... April 29, 2017 , ... TransDark is a set of dynamic transitions ... the next without having to set a single keyframe in Final Cut Pro ... video production. , TransDark features dynamic transitions that momentarily splits the RGB layers of ...
(Date:4/28/2017)... ... April 28, 2017 , ... An April 24th article on Yahoo! Beauty discusses ... with the help of a weight loss surgery. The woman, declaring “I will not hate ... been left following her dramatic weight loss. Dr. Feiz & Associates notes that, while it ...
(Date:4/28/2017)... ... 2017 , ... Beginning in 2017, Ridgecrest Herbals will be phasing out the ... ClearLungs Extra Strength formula. To ensure that the effectiveness of Clear Lungs Extra Strength ... , Removal of the homeopathic element , Adding their ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio ... These lamps offer an instant energy-saving solution for F32T8 fluorescent lamps on most ... disconnect ballasts. These 50,000 hour rated lamps utilize the existing electronic ballast, saving ...
(Date:4/28/2017)... ... April 28, 2017 , ... From April 30 to May ... Medicine will host industry leaders for the annual spring Convention & Expo, called ... industry adapt to the issues currently affecting urgent care and on-demand healthcare. , ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... consumer product development program, based on its proprietary ... Investigative Dermatology (SID) 76 th Annual Meeting.  ... the sciences relevant to skin health and disease ...
(Date:4/20/2017)... 20, 2017   ZappRx, Inc ., a digital health ... process, today announced it closed $25 million in Series B ... firm based in Seattle that is ... . The Series B round included participation from SR ... and GV (formerly Google Ventures). As part of ...
(Date:4/20/2017)... -- Eyevensys, a private biotechnology company developing ... technology that enables the safe, local, sustained production of ... range of ophthalmic diseases, announces it has received approval ... (MHRA) to advance its technology into clinical development. ... The EyeCET platform ...
Breaking Medicine Technology: